Cargando…

Potential inflammatory targets in the integrative health care of patients with sickle cell disease

Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shahida A, Halawani, Saeed H, Zughaibi, Torki Al, Khan, Sarah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515103/
https://www.ncbi.nlm.nih.gov/pubmed/37745045
http://dx.doi.org/10.3892/etm.2023.12184
_version_ 1785108875641356288
author Khan, Shahida A
Halawani, Saeed H
Zughaibi, Torki Al
Khan, Sarah A
author_facet Khan, Shahida A
Halawani, Saeed H
Zughaibi, Torki Al
Khan, Sarah A
author_sort Khan, Shahida A
collection PubMed
description Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. As disease severity increases with age, the present study aimed to assess if age is also correlated with a definite pattern of progression of the two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and total homocysteine (tHCY). The findings of the present study could lead to an improved understanding of the threshold levels of these inflammatory markers and timely interventions to delay complications. In an observational study, levels of hsCRP and tHCY were analyzed in 70 patients (35 male and 35 female patients) with SCD aged between 5 and 16 years. hsCRP levels were in the high-risk range in 64.29% (n=45) of all male and female patients. A sex-wise distribution showed that, of the 35 male patients, 74.28% (n=26) were in the high-risk range, and of the 35 female patients, 54.28% (n=19) were in the high-risk range. An age-wise distribution showed that of the 41 patients in the 5-10-years age group, 70.73% (n=29), were in the high-risk range. In comparison, of the 29 patients in the 11-16-years age group, 55.17% (n=16) were in the high-risk range. tHCY levels were observed to be in the normal range in 98.57% (n=69) of all children, as compared with 1.43% (n=1) in the high-risk range. Furthermore, a sex-wise distribution showed that female patients in the high-risk group of hsCRP had higher concentrations of tHCY as compared with the male patients in that risk group. An age-wise distribution of hsCRP concentration also showed that the risk of CVD in patients in the 11-16-years age group was higher with increased concentrations of tHCY. A weak negative correlation was observed between age and hsCRP concentrations (r-value=-0.280; P=0.026) and a weak positive correlation was detected between tHCY and age (r-value=0.259; P=0.036). In conclusion, the results of the present study indicated that higher levels of hsCRP could be a useful marker in children with SCD, and levels of tHCY may be an adjunct marker as the disease progresses with age.
format Online
Article
Text
id pubmed-10515103
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-105151032023-09-23 Potential inflammatory targets in the integrative health care of patients with sickle cell disease Khan, Shahida A Halawani, Saeed H Zughaibi, Torki Al Khan, Sarah A Exp Ther Med Articles Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. As disease severity increases with age, the present study aimed to assess if age is also correlated with a definite pattern of progression of the two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and total homocysteine (tHCY). The findings of the present study could lead to an improved understanding of the threshold levels of these inflammatory markers and timely interventions to delay complications. In an observational study, levels of hsCRP and tHCY were analyzed in 70 patients (35 male and 35 female patients) with SCD aged between 5 and 16 years. hsCRP levels were in the high-risk range in 64.29% (n=45) of all male and female patients. A sex-wise distribution showed that, of the 35 male patients, 74.28% (n=26) were in the high-risk range, and of the 35 female patients, 54.28% (n=19) were in the high-risk range. An age-wise distribution showed that of the 41 patients in the 5-10-years age group, 70.73% (n=29), were in the high-risk range. In comparison, of the 29 patients in the 11-16-years age group, 55.17% (n=16) were in the high-risk range. tHCY levels were observed to be in the normal range in 98.57% (n=69) of all children, as compared with 1.43% (n=1) in the high-risk range. Furthermore, a sex-wise distribution showed that female patients in the high-risk group of hsCRP had higher concentrations of tHCY as compared with the male patients in that risk group. An age-wise distribution of hsCRP concentration also showed that the risk of CVD in patients in the 11-16-years age group was higher with increased concentrations of tHCY. A weak negative correlation was observed between age and hsCRP concentrations (r-value=-0.280; P=0.026) and a weak positive correlation was detected between tHCY and age (r-value=0.259; P=0.036). In conclusion, the results of the present study indicated that higher levels of hsCRP could be a useful marker in children with SCD, and levels of tHCY may be an adjunct marker as the disease progresses with age. D.A. Spandidos 2023-09-01 /pmc/articles/PMC10515103/ /pubmed/37745045 http://dx.doi.org/10.3892/etm.2023.12184 Text en Copyright: © Khan et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Khan, Shahida A
Halawani, Saeed H
Zughaibi, Torki Al
Khan, Sarah A
Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title_full Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title_fullStr Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title_full_unstemmed Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title_short Potential inflammatory targets in the integrative health care of patients with sickle cell disease
title_sort potential inflammatory targets in the integrative health care of patients with sickle cell disease
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515103/
https://www.ncbi.nlm.nih.gov/pubmed/37745045
http://dx.doi.org/10.3892/etm.2023.12184
work_keys_str_mv AT khanshahidaa potentialinflammatorytargetsintheintegrativehealthcareofpatientswithsicklecelldisease
AT halawanisaeedh potentialinflammatorytargetsintheintegrativehealthcareofpatientswithsicklecelldisease
AT zughaibitorkial potentialinflammatorytargetsintheintegrativehealthcareofpatientswithsicklecelldisease
AT khansaraha potentialinflammatorytargetsintheintegrativehealthcareofpatientswithsicklecelldisease